Gilead Prevails In Antiviral IP Claim Fight At Fed. Circ.
The Federal Circuit on Monday backed a Patent Trial and Appeal Board finding in favor of Gilead that threw out more than two dozen claims in a University of Minnesota patent...To view the full article, register now.
Already a subscriber? Click here to view full article